Genky DrugStores Co., Ltd.
2026 Fiscal Year Supplementary Financial Data | Sales of approximately 244 billion yen (YoY +10.6%)
Genky DrugStores' FY2026 first-half financial supplement shows achieved sales of approximately 244 billion yen (YoY +10.6%), with store count also expanding. The company continues to pursue aggressive store expansion and revenue growth.
Key Figures
- Sales: approximately 244 billion yen (YoY +10.6%)
- Number of Stores: 604 stores
- Net Income: approximately 220 million yen (YoY +12.4%)
AI要約
Performance Overview
In the first half of FY2026, Genky DrugStores achieved sales of approximately 244 billion yen (YoY +10.6%), expanding its store count to 604 locations. The increase in sales from new openings and existing stores has improved profitability. Net income remained steady at approximately 220 million yen, indicating a solid performance, and the company maintains its goal of active store expansion and revenue growth.
Future Outlook and Impact on Shareholders
The company will continue its active store expansion strategy, aiming to maintain sales of approximately 244 billion yen and over 600 stores in FY2027. Net income is expected to remain steady, and shareholder return measures such as maintaining dividends and treasury stock acquisitions are also suggested. Investors can expect stable growth and improved earnings performance.
Genky DrugStores
Company overview · Stock price · Financial data · All IR
